Clinical Trial Update: Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial update on SPD476 for maintaining remission in ulcerative colitis; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• SPD476

Snippet

Sponsor: Shire | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2010-09-21